New Research Reinforces Prevalence of Trismus in HNC Patients up to 10 Years Post Treatment
Posted by Sarah Schuman, MS, CCC-SLP on 7/23/2019 to
Head & Neck Cancer, Radiation Therapy
New Research! Systematic review and meta-analysis reinforces the significant prevalence of trismus (equal to or less than 35 mm MIO) in HNC patients up to 10 years post treatment.
HPV Vaccine is Key in Fight Against Cancer
Posted by Sarah Schuman, MS, CCC-SLP on 7/1/2019 to
General Medical and Dental Information
HPV Vaccine In The News!!!!
In June 2019, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices approved the use of the HPV vaccine in some people through the age of 45. By expanding the pool of approved people, more insurance providers may cover the vaccine.